The underlying mechanisms mainly involve promoting the polarization of tumor-associated macrophages (TAMs) toward an immunostimulatory phenotype, thereby enhancing their antitumor activity, and activating effector CD8+ T cells within the tumor microenvironment, which increases their cytotoxicity and antitumor functions. The gene discussed is CD8A; the disease is neoplasm.